Consistent with this previous work, we report here that IL-2Rα overexpression in NKTCL cells led to chemoresistance in vitro to gemcitabine, doxorubicin, and l-Asp. The gene discussed is IL2RA; the disease is extranodal nasal NK/T cell lymphoma.